› $150,000,000 verdict in personal injury case
Wyeth, the pharmaceutical company that makes hormone replacement therapies Prempro and Premarin, announced today that it is ending its research in its signature areas of contraceptives and menopause treatments to focus on other female problems such as ovarian and breast cancers, according to the Associated Press/Washington Post.
Strong bones may make older, post-menopausal women at greater risk for breast cancer, according to a study conducted by University of Arizona, reported by KABC-TV in Los Angeles.
Bone scans are used to check for osteoporosis, a disease in which bones become fragile and more likely to break. Women are typically four times more likely than men to suffer from osteoporosis. Because there is a direct relationship between the lack of estrogen after menopause and the development of osteoporosis, most doctors advise older women to have bone density tests every year along with a mammogram.
Ovarian cancer is the deadliest of all gynecologic cancers, expected to kill about 15,000 women in 2008, according to the Ovarian Cancer National Alliance. Risk factors remain a mystery; however, researchers believe a woman is at increased risk if she has a family history of cancer, personal history of cancer, is older than 55, has never been pregnant, and has used menopausal hormone therapy.
Menopause hit Terri Myerson like a high-temperature hurricane breeze, jolting her awake with at night with dripping sweats. For relief, she turned to a most unexpected treatment – acupuncture.
Breast cancer is a disease that affects women all around the world. One in eight women in the U.S. has the disease, one out of 10 in Europe, and one out of 11 in Australia. In Pakistan, the ratio is three in 10.
Earlier this week, as part of October’s international breast cancer awareness month, leaders from Liaquat National Hospital in Pakistan addressed the issue and their concern over why so many Pakistani women are still unaware of the disease, according to the Daily Times.
Once thought of as a cure-all for a host of menopausal symptoms with benefits ranging from increased bone strength and protection against heart disease, hormone replacement therapy (HRT) continues to come under fire for causing more harm than good. Now researchers believe that women who survived breast cancer and then took HRT to relieve menopause symptoms may be at a significantly higher risk for breast cancer recurrence, according to Natural News.
How and when women take hormone replacement therapy (HRT) may affect their risk of heart attack, according to the Washington Post.
Medications typically taken for pain relief may help reduce the risk of some breast cancers, according to a recent article in the Journal of the National Cancer Institute.
Researchers analyzed data from 38 observational studies involving more than 2.7 million women to see whether taking non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, reduced risk of breast cancer. Inflammation may be a risk factor in cancer, the report says.
Every woman approaching menopause or currently suffering from the symptoms of menopause has questions. How bad will the symptoms be? What is the best way to manage the symptoms? Will the treatment make me sick? Am I the only one who feels this way? In order to find answers most women have to educate themselves, and that can be a monumental task.
October is breast cancer awareness month, which makes it a perfect time for women currently taking or considering taking hormone replacement therapy (HRT), to assess their breast health.
